{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T08:30:35Z","timestamp":1774686635838,"version":"3.50.1"},"reference-count":41,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2009,2,2]],"date-time":"2009-02-02T00:00:00Z","timestamp":1233532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Clinical Hypertension"],"published-print":{"date-parts":[[2009,11]]},"abstract":"<jats:p>There are many factors that increase the risk of cardiovascular disease, and a prominent factor among these is dyslipidemia. The following literature review focuses on the use of niacin therapy in order to treat dyslipidemia and how to control the associated \u201cniacin flush.\u201d The associated studies gathered are reviews and randomized control trials. They were obtained by using electronic searches. Certain keywords took precedence, and articles focusing on niacin therapy were chosen. Recent research has found promising insight into more effective prevention of the niacin\u2010mediated flush through a selective antagonist for the prostaglandin D2 receptor, laropiprant. Aspirin (or NSAIDs) also provide some prevention for flushing, although recent studies have shown that it is not as effective as laropiprant. There is a need for further research in order to come to a clear conclusion regarding combined therapies of aspirin and laropiprant pretreatment, as well as exact dosage requirements.<\/jats:p>","DOI":"10.1111\/j.1559-4572.2008.00050.x","type":"journal-article","created":{"date-parts":[[2009,2,2]],"date-time":"2009-02-02T18:43:03Z","timestamp":1233600183000},"page":"685-689","source":"Crossref","is-referenced-by-count":19,"title":["Mechanisms of Flushing Due to Niacin and Abolition of These Effects"],"prefix":"10.1111","volume":"11","author":[{"given":"Aditya","family":"Sood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit","family":"Arora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,10,28]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(86)80293-5"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.106.030833"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.hco.0000231404.76930.e9"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncpcardio0500"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011090"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-139-12-200312160-00009"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(98)00731-0"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(98)00732-2"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1177\/0091270007300264"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1368-5031.2004.00233.x"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200565180-00014"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(98)90284-0"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(64)90149-3"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1989.200"},{"key":"e_1_2_8_16_2","first-page":"33","volume-title":"Metabolic Effects of Nicotinic Acid and Its Derivatives","author":"Fumagalli R","year":"1971"},{"key":"e_1_2_8_17_2","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/clinchem\/22.11.1821","article-title":"Metabolic responses of humans to ingestion of nicotinic acid and nicotinamide","volume":"22","author":"Mrochek JE","year":"1976","journal-title":"Clin Chem"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/60.suppl_2.S9"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(00)01468-5"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(03)00342-5"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm824"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M210695200"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16359-9"},{"key":"e_1_2_8_24_2","first-page":"271","article-title":"Identifcation of a nicotinic acid receptor. Is that the molecular target for the oldest lipid lowering drug?","volume":"5","author":"Pike NB","year":"2004","journal-title":"Curr Opin Investig Drugs"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI23626"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm824"},{"key":"e_1_2_8_27_2","volume-title":"Nicotinic Acid Induces Secretion of Prostaglandin D2 in Human Macrophages: An In vitro Model of the Niacin Flush","author":"Meyers CD"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700586"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.7.4362"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/HCO.0b013e3283021c82"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1977.tb02116.x"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1977.tb02678.x"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1368-5031.2006.00957.x"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-142-2-200501180-00008"},{"key":"e_1_2_8_35_2","volume-title":"Niaspan Prescribing Information"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/00045391-199506000-00006"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.1997.07118.x"},{"key":"e_1_2_8_38_2","first-page":"165","article-title":"The effect of aspirin on niacin\u2010induced cutaneous reactions","volume":"34","author":"Whelan AM","year":"1992","journal-title":"J Fam Pract"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1982.63"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100180"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100345"},{"key":"e_1_2_8_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.10.023"}],"container-title":["The Journal of Clinical Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1559-4572.2008.00050.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1559-4572.2008.00050.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T21:49:53Z","timestamp":1697320193000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1559-4572.2008.00050.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,28]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["10.1111\/j.1559-4572.2008.00050.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1559-4572.2008.00050.x","archive":["Portico"],"relation":{},"ISSN":["1524-6175","1751-7176"],"issn-type":[{"value":"1524-6175","type":"print"},{"value":"1751-7176","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,28]]}}}